Preoperative Sleep Intervention on Postoperative Delirium in School-aged Children Undergoing Congenital Heart Surgery

May 27, 2025 updated by: Yan Fuxia

The Impact of Cognitive Behavioral Intervention On Postoperative Delirium In School-aged Children With Sleep Disorder Undergoing Congenital Heart Surgery: A Multicenter, Randomized Controlled Clinical Trial

This is a multicenter, randomized, controlled clinical trial aimed to determine whether preoperative sleep interventions could reduce the incidence of adverse outcomes, such as postoperative delirium, in sleep-disordered school-aged children undergoing congenital heart surgery. The study will include infants and toddlers undergoing elective cardiac surgery with sleep disorders, assessed by the Children's Sleep Habits Questionnaire (CSHQ). All participants will be randomly assigned to the intervention group and Controll group in a 1:1 ratio. The intervention group received a short intensive cognitive-behavioral intervention 7-14 days before surgery, and no intervention was imposed on the control group. The results of this study will provide suggestions for the prevention of delirium after cardiac surgery.

Study Overview

Detailed Description

The study will be carried out in Fuwai Hospital, Chinese Academy of Medical Sciences, Anzhen Hospital Affiliated to Capital Medical University, Fuwai Central China Cardiovascular Hospital, Fuwai Cardiovascular Hospital of Yunnan Province, and Children's Hospital Affiliated to Capital Institute of Pediatrics.

The research process is as follows: Conduct a routine assessment of sleep disorders for the children visiting the outpatient clinic. The guardians fill out the online Children's Sleep Habits Questionnaire. Fully inform the children with sleep disorders and their guardians of all the contents and procedures of this trial. After obtaining informed consent and signing the informed consent form, conduct a further assessment on the children to determine whether they meet the inclusion and exclusion criteria. All enrolled children and their guardians will receive preoperative education for congenital heart disease in the outpatient clinic. After stratification by research center, the random block is set to 4 - 6, the R will be used to randomly assign subjects to the experimental group and the control group at a 1:1 ratio. After randomization, the parents of children in the experimental group register for a WeChat mini-program, and the children receive cognitive-behavioral interventions every day before surgery. Guardians need to strictly implement and cooperate with researchers through phone calls (during the waiting period for admission) or face-to-face communication (during the preoperative hospitalization period). The control group does not receive any intervention and follows routine clinical practice. To better control the quality of interventions for children aged 6 - 12 in the experimental group, the daily implementation status of parents is counted for the degree of implementation (0 - 100%) in the WeChat mini-program. Guardians record the children's daily sleep diaries (online questionnaires) before surgery. The day before surgery, parents fill out the online Children's Sleep Habits Questionnaire again and compare the scores with the baseline scores. After admission, children wear actigraphs until the day of surgery and until discharge after surgery to automatically record sleep-related information. After the children are enrolled in the study, relevant researchers will supervise the implementation of cognitive-behavioral interventions for the children once a day before surgery to ensure that the actigraph device functions properly during hospitalization and remind guardians to record electronic sleep diaries until the night before surgery. Follow-up will be conducted within 7 days after surgery or before discharge to evaluate outcomes such as delirium and pain. The primary outcome is the incidence of postoperative delirium, and secondary outcomes include postoperative sleep quality, pain score, perioperative organ injury (including AKI, acute lung injury, and postoperative liver dysfunction), clinical recovery and prognosis.

Study Type

Interventional

Enrollment (Estimated)

544

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Beijing, China, 100037
        • Recruiting
        • Fuwai Hospital, Chinese Academy of Medical Sciences
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Age 0-36 months
  2. Scheduled to undergo elective corrective surgery for congenital heart disease under cardiopulmonary bypass.
  3. Sleep disorder assessed by Children's Sleep Habits Questionnaire (CSHQ) (CSHQ score >48)

Exclusion Criteria:

  1. Preoperative use of sleep therapy-related medications
  2. The risk adjustment in congenital heart surgery-1 (RACHS-1 classification) ≥4
  3. History of preoperative cardiac assist device, mechanical ventilation support, or asphyxia rescue
  4. Emergency surgery or preoperative ICU admission
  5. History of neurodevelopmental disorders such as autism spectrum disorder, attention deficit hyperactivity disorder, or psychiatric disorders such as depression
  6. Combined severe hepatic and renal dysfunction
  7. Combination of non-cardiac malformations (adenoid hypertrophy, tracheobronchial stenosis, polysplenism, anaplastic syndrome, Down syndrome, DiGeoge syndrome, diabetes mellitus, reproductive system abnormalities, anal atresia and Williams syndrome, eye disorders)
  8. History of preoperative cerebral ischemia and hypoxia
  9. Concurrent participation in other clinical trials
  10. Refusal of the family to sign the informed consent form or poor compliance by the child

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CBT group
The intervention group received a short intensive cognitive-behavioral therapy (CBT) intervention 7-14 days before surgery
After enrollment in the experimental group, the guardians were asked to fill out a sleep diary every day before surgery to self-report the children's sleep, and to wear a somatic movement recorder to monitor sleep (non-dominant arm) (wGT3x-BT accelerometer, ActiGraph) during the preoperative hospitalization period, except during surgery, and then to wear it to record the sleep-related parameters until 7 days after surgery or before discharge from the hospital.Preoperative daily cognitive-behavioral interventions (developmental trials were guided with WeChat applets), including cognitive change, sleep hygiene, sleep restriction, stimulus control, and relaxation training
No Intervention: control group
no intervention was imposed on the control group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The incidence of postoperative delirium
Time Frame: Postoperative 7 days
Postoperative 7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The incidence of postoperative Liver dysfunction
Time Frame: Postoperative 7 days
Postoperative 7 days
The incidence of postoperative Acute kidney injury
Time Frame: Within postoperative 7 days
Within postoperative 7 days
The incidence of Pulmonary complication
Time Frame: Postoperative 7 days
Postoperative 7 days
Types and dosages of drugs used for postoperative sedation and analgesia
Time Frame: Postoperative 7 days or before discharge
Postoperative 7 days or before discharge
The length of intensive care unit stay
Time Frame: From the end of the surgery to discharge from the hospital,up to 30 days
The time spent in the intensive care unit.
From the end of the surgery to discharge from the hospital,up to 30 days
The length of postoperative hospital stay
Time Frame: From the end of the surgery to the day of discharge from the hospital,up to 30 days
From the end of the surgery to the day of discharge from the hospital,up to 30 days
Average daily cost
Time Frame: admission to discharge, up to 30days
total hospitalization cost divided by total length of stay
admission to discharge, up to 30days
Concentration of intestinal fatty acid binding protein (I-FABP)
Time Frame: before surgery, at the end of surgery and 24 hours after surgery
one of markers of intestinal injury
before surgery, at the end of surgery and 24 hours after surgery
Concentration of zonulin
Time Frame: before surgery, at the end of surgery and 24 hours after surgery
One of markers of intestinal injury
before surgery, at the end of surgery and 24 hours after surgery
Concentration of lipopolysaccharide (LPS)
Time Frame: before surgery, at the end of surgery and 24 hours after surgery
one of markers of intestinal injury
before surgery, at the end of surgery and 24 hours after surgery
Concentration of lipopolysaccharide binding protein (LBP)
Time Frame: before surgery, at the end of surgery and 24 hours after surgery
One of markers of intestinal injury
before surgery, at the end of surgery and 24 hours after surgery
Concentration of IL-6
Time Frame: before surgery, at the end of surgery and 24 hours after surgery
before surgery, at the end of surgery and 24 hours after surgery
Concentration of TNF-α
Time Frame: before surgery, at the end of surgery and 24 hours after surgery
before surgery, at the end of surgery and 24 hours after surgery
Concentration of IL-1β
Time Frame: before surgery, at the end of surgery and 24 hours after surgery
before surgery, at the end of surgery and 24 hours after surgery
Concentration of IFN-γ
Time Frame: before surgery, at the end of surgery and 24 hours after surgery
before surgery, at the end of surgery and 24 hours after surgery
Concentration of IL-17
Time Frame: before surgery, at the end of surgery and 24 hours after surgery
before surgery, at the end of surgery and 24 hours after surgery
Concentration of C-reactive protein
Time Frame: before surgery, at the end of surgery and 24 hours after surgery
before surgery, at the end of surgery and 24 hours after surgery
The duration of postoperative mechanical ventilation
Time Frame: From the end of the surgery to the removal of the tracheal intubation,up to 30days
From the end of the surgery to the removal of the tracheal intubation,up to 30days
Mechanistic endpoint: Concentration of plasma S-100β protein
Time Frame: Before surgery, at the end of surgery and 24 hours after surgery
S-100β protein was used as a surrogate biomarker for the disruption of the blood-brain barrier.
Before surgery, at the end of surgery and 24 hours after surgery
Pain defined by the Wong-Baker faces pain scale (revision)
Time Frame: Postoperative 7 days
The Faces Pain Scale-Revised (FPS-R) requires patients to rate their overall pain intensity on a scale from 0 (no pain) to 10 (worst possible pain). Simultaneously, the FPS-R provides six cartoon illustrations of facial expressions (ranging from smiling, sad, to agonized crying) to visually represent the pain levels corresponding to different score ranges. This design aligns with children's concrete thinking characteristics. During assessment, the child simply points to the numerical rating or cartoon face that best matches their perceived pain intensity, making it particularly suitable for children aged 4 to 12 years.
Postoperative 7 days

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Long-term Sleep quality score
Time Frame: 30 days, six months, 1 year postoperatively
guardians scored sleep quality 1-5 using a sleep diary
30 days, six months, 1 year postoperatively
Strengths and Difficulties Questionnaire Score
Time Frame: 6 months and 1 year after surgery
The Strengths and Difficulties Questionnaire (SDQ) consists of 25 items (0-50 scores) assessing five main domains: emotional symptoms, behavioral problems, oppositional behaviors, peer relationship problems, and social competence. These dimensions allow researchers to get a comprehensive picture of a child's emotional and behavioral status, with higher scores being more severe. Guardians will be required to complete the electronic SDQ Parent Version Questionnaire at 6 months postoperatively and 1 year postoperatively
6 months and 1 year after surgery
Readmission rate
Time Frame: 30 days,6 months,1 year after discharge
the rate at which a patient is readmitted to the hospital for the same or a different health problem within 30 days/six months/1 year after discharge
30 days,6 months,1 year after discharge
1-year mortality
Time Frame: 1 year after surgery
the death rate of 1 year after surgery
1 year after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Fuxia Yan, Chinese Academy of Medical Sciences, Fuwai Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 28, 2025

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

February 25, 2025

First Submitted That Met QC Criteria

March 14, 2025

First Posted (Actual)

March 17, 2025

Study Record Updates

Last Update Posted (Actual)

May 31, 2025

Last Update Submitted That Met QC Criteria

May 27, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Congenital Heart Disease (CHD)

Clinical Trials on cognitive-behavioral intervention

Subscribe